Luxembourg, July 31 -- The European Investment Bank (EIB) has signed a €20 million venture debt financing agreement with Finnish life-science technology innovator Aiforia. The funding will support the further development of the company's AI powered platform, designed to support pathologists in digital tissue analysis (digital pathology), notably for the detection of tumours. The software examines ultra-high-resolution images of biopsy samples to identify cancer cells with high precision and speed. The EIB backing for Aiforia is supported under the European Commission's InvestEU programme. Aiforia plans to use the financing to accelerate its product development projects related to existing and new image analysis solutions, as well as t...